SAR425899



NAME OF DRUG : SAR425899

ALSO KNOWN AS : SAR425899

LABORATORY : SANOFI

STATUS AND ADVANCEMENT

Type of drug : GLP-1/GCGR agonist

Clinical trials advancement : Initiating Phase 2a

Estimated time to market : 123 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON SAR425899

SOME PUBLICATIONS RELATED WITH SAR425899

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH SAR425899


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE